The differential functional coupling of phosphodiesterase 4 to human DP and EP2 prostanoid receptors stimulated with PGD2 or PGE2

被引:2
|
作者
Okura, Iori [1 ]
Hasuoka, Nanae [2 ,3 ]
Senoo, Kanaho [2 ,3 ]
Suganami, Akiko [4 ]
Fukushima, Keijo [2 ,3 ]
Regan, John W. [5 ]
Mashimo, Masato [6 ]
Murayama, Toshihiko [1 ]
Tamura, Yutaka [4 ]
Fujino, Hiromichi [2 ,3 ]
机构
[1] Chiba Univ, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan
[2] Tokushima Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol Life Sci, Tokushima 7708505, Japan
[3] Tokushima Univ, Grad Sch Biomed Sci, Tokushima 7708505, Japan
[4] Chiba Univ, Grad Sch Med, Dept Bioinformat, Chiba 2608670, Japan
[5] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA
[6] Doshisha Womens Coll Liberal Arts, Fac Pharmaceut Sci, Pharmacol Lab, Kyoto 6100311, Japan
关键词
Human DP receptors; Human EP2 receptors; PGD(2); PGE(2); PDE4; PROSTAGLANDIN RECEPTOR; ASSOCIATION; CLONING; GENE;
D O I
10.1007/s43440-021-00247-x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background Human DP and EP2 receptors are two of the most homologically related receptors coupling with G(alpha)s-protein, which stimulate adenylyl cyclase to produce cAMP. Indeed, both receptors are considered to be generated by tandem duplication. It has been reported that other highly homologous and closely related beta 1- and beta 2-adrenergic receptors interact distinctly with and differentially regulate cAMP-specific phosphodiesterase (PDE) 4 recruitment. Methods First, we focused on the cAMP degradation pathways of DP and EP2 receptors stimulated by prostaglandin (PG) D-2 or PGE(2) using HEK cells stably expressing either human DP receptors or EP2 receptors. Then, distances between ligands and amino acids of the receptors were evaluated by molecular dynamics (MD) analysis. Results We found that PGD(2)/EP2 receptors exerted a greater effect on PDE4 activity than PGE(2)/EP2 receptors. Moreover, by MD analysis, either the PGD(2) or EP2 receptor was moved and the distance was shortened between them. According to the results, DP receptors retain reactivity for PGE(2), but EP2 receptors may be activated only by PGE(2), at least in terms of cAMP formation, through the differential functional coupling of PDE4 probably with beta-arrestin. Conclusion Since DP receptors and EP2 receptors are considered to be duplicated genes, DP receptors may still be in a rapid evolutionary stage as a duplicated copy of EP2 receptors and have not yet sufficient selectivity for their cognate ligand, PGD(2).
引用
收藏
页码:946 / 953
页数:8
相关论文
共 50 条
  • [21] PGE2 differentially regulates monocyte-derived dendritic cell cytokine responses depending on receptor usage (EP2/EP4)
    Poloso, Neil J.
    Urquhart, Paula
    Nicolaou, Anna
    Wang, Jenny
    Woodward, David F.
    MOLECULAR IMMUNOLOGY, 2013, 54 (3-4) : 284 - 295
  • [22] The localization of PGE2 receptor subtypes in rat retinal cultures and the neuroprotective effect of the EP2 agonist butaprost
    da Silveira Andrade da Costa, Belmira Lara
    Kang, Kui Dong
    Rittenhouse, Kay D.
    Osborne, Neville N.
    NEUROCHEMISTRY INTERNATIONAL, 2009, 55 (04) : 199 - 207
  • [23] EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival
    Kamiyama, M.
    Pozzi, A.
    Yang, L.
    DeBusk, L. M.
    Breyer, R. M.
    Lin, P. C.
    ONCOGENE, 2006, 25 (53) : 7019 - 7028
  • [24] EP2, a receptor for PGE2, regulates tumor angiogenesis through direct effects on endothelial cell motility and survival
    M Kamiyama
    A Pozzi
    L Yang
    L M DeBusk
    R M Breyer
    P C Lin
    Oncogene, 2006, 25 : 7019 - 7028
  • [25] Human granulosa-lutein cells express functional EP1 and EP2 prostaglandin receptors
    Harris, TE
    Squires, PE
    Michael, AE
    Bernal, AL
    Abayasekara, DR
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 285 (05) : 1089 - 1094
  • [26] Prostaglandin E2 (PGE2) suppresses natural killer cell function primarily through the PGE2 receptor EP4
    Holt, Dawn
    Ma, Xinrong
    Kundu, Namita
    Fulton, Amy
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2011, 60 (11) : 1577 - 1586
  • [27] Potential therapeutic interventions via EP2/EP4 prostaglandin receptors
    Zimecki, Michal
    POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2012, 66 : 287 - 294
  • [28] Pharmacological evidence that the inhibitory effects of prostaglandin E2 are mediated by the EP2 and EP4 receptors in human neutrophils
    Lavoie, Jean-Philippe C.
    Simard, Melissa
    Kalkan, Hilal
    Rakotoarivelo, Volatiana
    Huot, Sandrine
    Di Marzo, Vincenzo
    Cote, Andreanne
    Pouliot, Marc
    Flamand, Nicolas
    JOURNAL OF LEUKOCYTE BIOLOGY, 2024, 115 (06) : 1183 - 1189
  • [29] Involvement of EP2 and EP4 Receptors in Eosinophilic Esophagitis: A Pilot Study
    Durchschein, Franziska
    Eherer, Andreas
    Grill, Magdalena
    Sturm, Eva M.
    Pommer, Veronika
    Langner, Cord
    Hoegenauer, Christoph
    Schicho, Rudolf
    DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (10) : 2806 - 2814
  • [30] Effect of MP-AzeFlu compared to monotherapy on COX-2, PGE2, and EP2 gene expression in upper airway mucosa
    Vicens-Artes, Sonia
    Roca-Ferrer, Jordi
    Tubita, Valeria
    Fuentes, Mireya
    Alobid, Isam
    Valero, Antonio
    Kopietz, Ferdinand
    Nguyen, DucTung
    Mullol, Joaquim
    IMMUNITY INFLAMMATION AND DISEASE, 2023, 11 (01)